Lyophilized (freeze-dried) sterile powders for injection/infusion
company profile
Corporate presentation covering overview, history (since 1967), the 5 units, licensing & international sales (129 countries, 807 marketing authorizations), R&D, CMC & regulatory affairs, manufacturing (7,400 m² site, lyophilization 40M vials/yr, β-lactams 15M vials/yr, sterile liquids, oral dosage forms, serialization), logistics (3,500 m²), quality, and upcoming milestones.
brochure
Two-page product-list flyer grouping the portfolio into dry powders / lyophilized, solutions for injection/infusion, non-sterile / oral dosage forms, and ongoing (ready-to-file) products with availability timelines.
catalog
International product list of ANFARM generic pharmaceuticals available for licensing and export.
Anfarm Hellas S.A.
Contactez directement Anfarm Hellas S.A. pour demander les prix, des échantillons et les délais de livraison pour Lyophilized & Freeze-Dried Injectables.
Anfarm's flagship manufacturing platform: freeze-dried (lyophilized) sterile powders for injection and infusion. Production capacity of 40 million vials per year across 10 freeze dryers and 4 dedicated production lines (1,400 m²), including lyophilization-cycle development and optimization for new molecules. The portfolio spans glycopeptide, lipopeptide, macrolide, glycylcycline and echinocandin anti-infectives, proton-pump inhibitors and other hospital injectables.
| Usage | Prescription-only (Rx) sterile injectable pharmaceuticals for hospital use |
|---|---|
| Dosage form | Lyophilized (freeze-dried) powder for solution for injection/infusion |
| Production capacity | 40 million vials per year vials/year |
| Freeze dryers | 10 |
| Production lines | 4 dedicated lyophilized lines |
| Production area | 1,400 m² |
| Variante | Strength | Dosage form | Therapeutic class | Status |
|---|---|---|---|---|
| AzithromycinMacrolide antibiotic, lyophilized powder for infusion | 500 mg/vial | Pd.Sol.Inf (powder for solution for infusion) | Macrolide antibiotic | — |
| CaspofunginEchinocandin antifungal | 50 mg & 70 mg/vial | Pd.C.So.In (powder for concentrate for solution for infusion) | Echinocandin antifungal | — |
| ClarithromycinMacrolide antibiotic | 500 mg/vial | Pd.Sol.Inf | Macrolide antibiotic | — |
| DalbavancinLong-acting lipoglycopeptide antibiotic | 500 mg/vial | Pd.C.So.In | Lipoglycopeptide antibiotic | — |
| DaptomycinCyclic lipopeptide antibiotic | 350 mg & 500 mg/vial | Pd.I.S.Inf (powder for injectable solution/infusion) | Lipopeptide antibiotic | — |
| EsomeprazoleProton-pump inhibitor | 40 mg/vial | Pd.I.S.Inf | Proton-pump inhibitor | — |
| OmeprazoleProton-pump inhibitor (injectable) | 40 mg/vial | Ps.Inj.Sol / Pd.Sol.Inf | Proton-pump inhibitor | — |
| PantoprazoleProton-pump inhibitor (injectable) | 40 mg/vial | Pd.Inj.Sol | Proton-pump inhibitor | — |
| SomatostatinGrowth-hormone-inhibiting hormone | 3 mg/vial | Ps.Sol.Inf (powder for solution for infusion) | Somatostatin analogue / GI hormone | — |
| TeicoplaninGlycopeptide antibiotic | 200 mg & 400 mg/vial | Pd.Sol.Inf | Glycopeptide antibiotic | — |
| TenoxicamNSAID (oxicam) for injection | 20 mg/vial | Ps.Inj.Sol (powder for solution for injection) | NSAID (oxicam) | — |
| TigecyclineGlycylcycline antibiotic | 50 mg/vial | Pd.Sol.Inf | Glycylcycline antibiotic | — |
| VancomycinGlycopeptide antibiotic (also available as oral solution) | 500 mg & 1 g/vial | Pd.Sol.Inf (+ oral solution) | Glycopeptide antibiotic | — |
| VoriconazoleTriazole antifungal | 200 mg/vial | Pd.Sol.Inf | Triazole antifungal | — |
| MicafunginEchinocandin antifungal (under registration) | 50 mg & 100 mg/vial | Pd.C.So.In | Echinocandin antifungal | Under registration / ready to file |
| RemifentanilUltra-short-acting opioid analgesic (under registration) | 1, 2 & 5 mg/vial | Pd.C.So.In | Opioid analgesic | Under registration / ready to file |
